从亚临床动脉粥样硬化到斑块进展与急性冠脉事件:JACC 前沿综述
本文综述提出斑块进展是早期动脉粥样硬化向斑块破裂演变的必要步骤。系列造影与CT血管成像数据显示,未显著进展的病变极少导致事件,无论狭窄程度或基线高危斑块形态如何。强化降脂至LDL-C<70 mg/dl可阻止斑块进展,基于早期动脉粥样硬化检测的个体化策略有望重新定义一级与二级预防范式。
要点
- 斑块进展是早期动脉粥样硬化与斑块破裂之间的可干预必要步骤。
- CT血管成像显示未显著进展的病变极少导致事件,与狭窄程度无关。
- 强化降脂至LDL-C<70 mg/dl可阻止斑块进展,支持基于早期检测的个体化预防。
核心结论
- 斑块进展可被视为早期非复杂性动脉粥样硬化与斑块破裂之间的必要步骤,且是可干预的环节。
研究设计与样本
- 本文为JACC前沿综述,汇总系列造影研究(事件前数月至1-3个月内造影数据)与非侵入性CT血管成像研究。
主要发现
- 系列造影研究显示,非阻塞性病变在急性事件发生前相对快速地进行性增大。
- CT血管成像数据证实,未随时间显著进展的病变极少导致事件,无论管腔狭窄程度或基线高危斑块形态如何。
- 强化降脂治疗至LDL-C<70 mg/dl可阻止斑块进展。
关键数值与推荐
- 强化降脂目标为低密度脂蛋白胆固醇<70 mg/dl时可阻止斑块进展。
临床怎么用
- 基于早期动脉粥样硬化检测的个体化策略可触发必要治疗以预防斑块进展和斑块不稳定。
- 该策略可重新定义基于人群风险估计的传统一级与二级预防范式,并可能改善长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It has been believed that most acute coronary events result from the rupture of mildly stenotic plaques, based on studies in which angiographic information was available from many months to years before the event. However, serial studies in which angiographic data were available from the past as also within 1 to 3 months of myocardial infarction have clarified that nonobstructive lesions progressively enlarged relatively rapidly before the acute event occurred. Noninvasive computed tomography angiography imaging data have confirmed that lesions that did not progress voluminously over time rarely led to events, regardless of the extent of luminal stenosis or baseline high-risk plaque morphology. Therefore, plaque progression could be proposed as a necessary step between early, uncomplicated atherosclerosis and plaque rupture. On the other hand, it has been convincingly demonstrated that intensive lipid-lowering therapy (to a low-density lipoprotein cholesterol level of <70 mg/dl) halts plaque progression. Given the current ability to noninvasively detect the presence of early atherosclerosis, the importance of plaque progression in the pathogenesis of myocardial infarction, and the efficacy of maximum lipid-lowering therapy, it has been suggested that plaque progression is a modifiable step in the evolution of atherosclerotic plaque. A personalized approach based on the detection of early atherosclerosis can trigger the necessary treatment to prevent plaque progression and hence plaque instability. Therefore, this approach can redefine the traditional paradigm of primary and secondary prevention based on population-derived risk estimates and can potentially improve long-term outcomes.
引用
- Ahmadi A, Argulian E, Leipsic J, et al. From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019. PMID: 31537271. doi:10.1016/j.jacc.2019.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。